Bruker (BRKR)

• Market cap: $6.38B
• 1 day: -3.15%
• 5 days: -6.16%
• 1 month: -10.89%
• 3 months: -28.07%
• 6 months: -39.07%
• Year to date: -28.45%
• 1 year: -55.21%
• 5 years: 9.16%
• 10 years: 124.43%
• Sector: Industrials
• Industry: Laboratory Analytical Instruments

About: Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.

Employees: 11,396

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

40% more funds holding in top 10

Funds holding in top 10: 5 [Q3] → 7 (+2) [Q4]

28% more repeat investments, than reductions

Existing positions increased: 145 | Existing positions reduced: 113

3.91% more ownership

Funds ownership: 76.94% [Q3] → 80.85% (+3.91%) [Q4]

5% more first-time investments, than exits

New positions opened: 66 | Existing positions closed: 63

1% less funds holding

Funds holding: 363 [Q3] → 361 (-2) [Q4]

10% less capital invested

Capital invested by funds: $7.95B [Q3] → $7.19B (-$760M) [Q4]

65% less call options, than puts

Call options by funds: $32.8M | Put options by funds: $93M

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $57 35% upside
• Avg. target: $59 39% upside
• High target: $60 43% upside

2 analyst ratings

• positive: 1 50%
• neutral: 1 50%
• negative: 0 0%

Stifel Daniel Arias 20% 1-year accuracy 4 / 20 met price target	35% upside $57	Hold Maintained	14 Feb 2025
Barclays Luke Sergott 25% 1-year accuracy 13 / 51 met price target	43% upside $60	Overweight Maintained	14 Feb 2025